Myleran Side Effects
|
|
Patientsville.com is the most complete Drug Side Effects Resource on the Internet. View over 1 million side effect patient episodes and learn about side effect symptoms and remedies. Connect with others who had similar side effects. Help Community by Submitting Your Side Effect.
Recently reported Myleran Side Effects
Did You Have Myleran Side Effect? |
Myleran Side Effects Poll Results |
|
Vote Below:
|
|
Myleran Comments and Questions
Join the discussion:
No comments have been provided.
Ask Community about Myleran:
What is Your Question? Ask Community:
Daily Health Videos
Myleran Side Effects reported on Patientsville.com
None reported at this time.Myleran Side Effects reported to FDA
Showing 1-50 of 51 Next >
Myleran Side Effects Report #5285850-4Consumer or non-health professional from UNITED STATES reported Myleran side effect on Mar 13, 2007. Female patient was diagnosed with aspiration bone marrow abnormal and was treated with Myleran. After drug was administered, patient experienced the following side effects: bone marrow failure, bone marrow transplant
, pancytopenia, trisomy 8. Myleran dosage: 37.5 MG/MIN/SEE TEXT/INTRAVENOUS. During the same period patient was treated with DAPSONE, PENTAMIDINE ISETHIONATE, CYANOCOBALAMIN, FOLIC ACID. Patient recovered.
Myleran Side Effects Report #5363593-6
Myleran side effect was reported by a Consumer or non-health professional from FRANCE on June 12, 2007. Female patient, 47 years of age, weighting 121.3 lb, was treated with Myleran. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung cyst benign, lung infiltration, obstructive airways disorder, pulmonary fibrosis
. Myleran dosage: 8MG PER DAY. During the same period patient was treated with ALKERAN, MELPHALAN. Patient was hospitalized. Patient recovered.Myleran Side Effects Report #5063371-1
Consumer or non-health professional from UNITED STATES reported Myleran side effect on Dec 27, 2005. Male patient, 73 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: laboratory test abnormal. Myleran dosage: unknown. Patient recovered.
Myleran Side Effects Report #5087223-6
Myleran side effect was reported by a Consumer or non-health professional from CANADA on Aug 03, 2006. Male patient, 54 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: cerebral atrophy, oedema. Myleran dosage: 12.8 MG/KG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE. Patient recovered.
Myleran Side Effects Report #5095334-4
Consumer or non-health professional from FRANCE reported Myleran side effect on Aug 24, 2006. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with acute leukaemia and was treated with Myleran. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung cyst benign, lung infiltration, pulmonary fibrosis
. Myleran dosage: unknown. During the same period patient was treated with MELPHALAN. Patient was hospitalized. Patient recovered.Myleran Side Effects Report #5106555-6
Myleran side effect was reported by a Consumer or non-health professional from FRANCE on Aug 24, 2006. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with acute leukaemia and was treated with Myleran. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung cyst benign, lung infiltration, obstructive airways disorder, pulmonary fibrosis
. Myleran dosage: 8MG PER DAY. During the same period patient was treated with ALKERAN, MELPHALAN. Patient was hospitalized. Patient recovered.Myleran Side Effects Report #5127290-4
Consumer or non-health professional from GERMANY reported Myleran side effect on Sept 29, 2006. Female patient, 55 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Myleran. After drug was administered, patient experienced the following side effects: abdominal pain
, activated partial thromboplastin time prolonged, ascites, cerebral haemorrhage, complications of bone marrow transplant, diarrhoea, flatulence, haemodialysis, hepatic failure. Myleran dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IG, CYCLOSPORINE, ACYCLOVIR, LEVOFLOXACIN, CYCLOPHOSPHAMIDE, FLUCONAZOLE, PREDNISONE. Patient died.Myleran Side Effects Report #5391222-4
Myleran side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: enterococcal sepsis. Myleran dosage: 1 MG/KG / SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.
Myleran Side Effects Report #5391247-9
Consumer or non-health professional from UNITED STATES reported Myleran side effect on July 10, 2007. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Myleran dosage: 1 MG/KG / SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.
Myleran Side Effects Report #5512944-8
Myleran side effect was reported by a Pharmacist from UNITED STATES on Nov 08, 2007. Female patient, 86 years of age, was diagnosed with polycythaemia vera and was treated with Myleran. After drug was administered, patient experienced the following side effects: pulmonary fibrosis
. Myleran dosage: unknown. During the same period patient was treated with LASIX, THYROID, HYDROXYUREA. Patient recovered.Myleran Side Effects Report #5609697-1
Consumer or non-health professional from POLAND reported Myleran side effect on Jan 22, 2008. Female patient, child 5 years of age, weighting 44.09 lb, was treated with Myleran. After drug was administered, patient experienced the following side effects: brain oedema, cardiovascular insufficiency, hepatomegaly, pulmonary oedema, respiratory failure, venoocclusive disease. Myleran dosage: unknown. During the same period patient was treated with ENDOXAN. Patient died on 10/22/2007.
Myleran Side Effects Report #5903323-X
Myleran side effect was reported by a Consumer or non-health professional from GERMANY on Sept 25, 2008. Female patient, 55 years of age, weighting 110.2 lb, was treated with Myleran. After drug was administered, patient experienced the following side effects: ageusia, aphthous stomatitis, paraesthesia, polyneuropathy. Myleran dosage: 4MG PER DAY. Patient recovered.
Myleran Side Effects Report #6004070-9
Consumer or non-health professional from SWEDEN reported Myleran side effect on Dec 10, 2008. Male patient, 27 years of age, was diagnosed with lymphoma
and was treated with Myleran. After drug was administered, patient experienced the following side effects: hearing impaired. Myleran dosage: unknown. During the same period patient was treated with FLUDARA, FRESENIUS, URSO FALK, DIFLUCAN, SANDIMMUNE, FRAGMIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, EMGESAN. Patient recovered.Myleran Side Effects Report #4606919-0
Myleran side effect was reported by a Consumer or non-health professional from on Feb 24, 2005. Female patient was diagnosed with bone marrow transplant
and was treated with Myleran. After drug was administered, patient experienced the following side effects: mucosal inflammation. Myleran dosage: 1 MG/KG/SEE TEXT/INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, STEM CELL TRANSPLANT. Patient died.Myleran Side Effects Report #4607695-8
Consumer or non-health professional from reported Myleran side effect on Feb 21, 2005. Female patient, 14 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: accidental overdose, convulsion, cytomegalovirus infection
, graft versus host disease, hyperbilirubinaemia, multi-organ failure, sepsis . Myleran dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IG. Patient recovered.Myleran Side Effects Report #4621370-5
Myleran side effect was reported by a Consumer or non-health professional from on Mar 14, 2005. Male patient, 40 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune. Myleran dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient recovered.
Myleran Side Effects Report #4626837-1
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, 15 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE COL. Patient recovered.
Myleran Side Effects Report #4626838-3
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, child 5 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, transplant failure. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE COL. Patient died.
Myleran Side Effects Report #4626839-5
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 3 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, febrile neutropenia, gastrointestinal toxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE COL. Patient died.Myleran Side Effects Report #4626840-1
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: complications of transplant surgery, febrile neutropenia, gastrointestinal toxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL. Patient died.Myleran Side Effects Report #4628649-1
Consumer or non-health professional from reported Myleran side effect on Mar 21, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: infection
. Myleran dosage: 3.2 MG/KG/SINGLE DOSE / INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient died.Myleran Side Effects Report #4629337-8
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient, 14 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE COL. Patient recovered.
Myleran Side Effects Report #4629338-X
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia, gastrointestinal toxicity, neurotoxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL. Patient recovered.Myleran Side Effects Report #4629339-1
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia, gastrointestinal toxicity, neurotoxicity. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL. Patient recovered.
Myleran Side Effects Report #4629340-8
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 4 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity, venoocclusive disease. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL. Patient recovered.
Myleran Side Effects Report #4629541-9
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, THIOTEPA, GRANULOCYTE COL. Patient recovered.Myleran Side Effects Report #4629542-0
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, THIOTEPA, GRANULOCYTE COL. Patient recovered.
Myleran Side Effects Report #4629544-4
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient, child 5 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, THIOTEPA, GRANULOCYTE COL. Patient recovered.Myleran Side Effects Report #4629545-6
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Female patient, child 9 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE COL. Patient recovered.
Myleran Side Effects Report #4629546-8
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, varicella. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE. Patient recovered.
Myleran Side Effects Report #4629548-1
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 4 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE COL. Patient recovered.
Myleran Side Effects Report #4629549-3
Myleran side effect was reported by a Consumer or non-health professional from on Mar 21, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: infection
. Myleran dosage: 1 MG/KG SEE TEXT/ ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.Myleran Side Effects Report #4629551-1
Consumer or non-health professional from reported Myleran side effect on Mar 21, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Myleran dosage: 1 MG/KG/ SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.
Myleran Side Effects Report #4630685-6
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient, child 6 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE. Patient recovered.Myleran Side Effects Report #4630688-1
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Female patient, 15 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE. Patient recovered.Myleran Side Effects Report #4630689-3
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, child 5 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: bone sarcoma, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE. Patient recovered.
Myleran Side Effects Report #4630690-X
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 12 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, venoocclusive disease. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE. Patient recovered.
Myleran Side Effects Report #4630696-0
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 14 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis
. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE. Patient recovered.Myleran Side Effects Report #4633874-X
Consumer or non-health professional from reported Myleran side effect on Apr 01, 2005. Male patient, 55 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: ascites, hepatic failure. Myleran dosage: 4 MG/KG/ VARIABLE DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IG, GRANULOCYTE COL. Patient died.
Myleran Side Effects Report #4633878-7
Myleran side effect was reported by a Consumer or non-health professional from on Apr 01, 2005. Male patient, 38 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: graft versus host disease. Myleran dosage: 4 MG/KG/ VARIABLE DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IG, GRANULOCYTE COL. Patient died.
Myleran Side Effects Report #4633883-0
Consumer or non-health professional from reported Myleran side effect on Apr 01, 2005. Male patient, 67 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: aspergillosis, graft dysfunction, graft versus host disease. Myleran dosage: 4 MG/KG/VARIABLE DOSE/ UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTIHYMOCYTE IG, GRANULOCYTE COL. Patient died.
Myleran Side Effects Report #4709621-X
Myleran side effect was reported by a Physician from INDIA on June 20, 2005. Female patient, 46 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Myleran. After drug was administered, patient experienced the following side effects: bacteria blood identified, bone marrow depression, bone marrow disorder, escherichia infection, febrile neutropenia, fibrosis, gastroenteritis
, lung infiltration. Myleran dosage: unknown. During the same period patient was treated with INTERFERON ALFA, IMATINIB MESYLATE, CYTARABINE. Patient was hospitalized. Patient died.Myleran Side Effects Report #4749068-3
Consumer or non-health professional from AUSTRALIA reported Myleran side effect on Aug 10, 2005. Female patient, 64 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, pneumonitis, pulmonary toxicity, respiratory failure. Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with ALKERAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE, ANTIBIOTICS, CORTICOSTEROID. Patient died.
Myleran Side Effects Report #4749070-1
Myleran side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 10, 2005. Male patient, 61 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: blood immunoglobulin g decreased, cough, influenza, lung infiltration, pneumonitis, pulmonary toxicity, respiratory failure, sepsis
, streptococcal infection . Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with MELPHALAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE. Patient died.Myleran Side Effects Report #4749071-3
Consumer or non-health professional from AUSTRALIA reported Myleran side effect on Aug 10, 2005. Male patient, 58 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: pneumonitis, pulmonary toxicity, pyrexia, respiratory failure. Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with ALKERAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE. Patient died.
Myleran Side Effects Report #4805329-0
Myleran side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2005. Male patient, 49 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: ascites, encephalopathy, international normalised ratio increased, multi-organ failure, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.
Myleran Side Effects Report #4805356-3
Consumer or non-health professional from UNITED KINGDOM reported Myleran side effect on Oct 05, 2005. Female patient, 34 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: encephalopathy, hepatic rupture, peritoneal haemorrhage, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, THIACETAZONE. Patient died.
Myleran Side Effects Report #4805358-7
Myleran side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2005. Female patient, 36 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: haemodialysis, international normalised ratio increased, renal impairment, respiratory failure, sepsis
, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.Myleran Side Effects Report #5034670-4
Consumer or non-health professional from GERMANY reported Myleran side effect on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease in skin, neutrophil count abnormal, platelet count decreased, sepsis
. Myleran dosage: 3.3 MG/KG/INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.Myleran Side Effects Report #5034671-6
Myleran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease in skin, neutrophil count abnormal, platelet count decreased. Myleran dosage: 3.3 MG/KG /INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Showing 1-50 of 51 Next >